NeueHealth, Inc. (NYSE:NEUE) Short Interest Down 25.8% in February

NeueHealth, Inc. (NYSE:NEUEGet Free Report) was the recipient of a large drop in short interest in February. As of February 28th, there was short interest totalling 9,200 shares, a drop of 25.8% from the February 13th total of 12,400 shares. Currently, 0.3% of the shares of the stock are short sold. Based on an average trading volume of 38,400 shares, the days-to-cover ratio is currently 0.2 days.

NeueHealth Price Performance

NeueHealth stock opened at $4.71 on Tuesday. NeueHealth has a 12-month low of $3.79 and a 12-month high of $7.66. The stock has a market capitalization of $38.98 million, a P/E ratio of -0.09 and a beta of 0.56. The firm’s 50-day moving average is $7.21 and its two-hundred day moving average is $6.01.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada decreased their price target on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research note on Monday, December 9th.

View Our Latest Stock Analysis on NEUE

Insider Buying and Selling at NeueHealth

In other NeueHealth news, CFO Jay Matushak sold 4,448 shares of the firm’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $6.74, for a total transaction of $29,979.52. Following the completion of the transaction, the chief financial officer now directly owns 41,592 shares in the company, valued at approximately $280,330.08. This trade represents a 9.66 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO George Lawrence Mikan III sold 31,798 shares of the firm’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $233,079.34. Following the sale, the chief executive officer now directly owns 146,539 shares in the company, valued at $1,074,130.87. This represents a 17.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 110,033 shares of company stock worth $774,560. 64.30% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On NeueHealth

Several hedge funds have recently modified their holdings of the stock. Partners Group Holding AG acquired a new stake in shares of NeueHealth in the third quarter worth approximately $463,000. Northern Trust Corp boosted its position in shares of NeueHealth by 66.8% in the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock worth $242,000 after acquiring an additional 13,074 shares during the last quarter. Finally, Virtu Financial LLC acquired a new stake in shares of NeueHealth in the fourth quarter worth approximately $76,000. 63.88% of the stock is owned by institutional investors and hedge funds.

About NeueHealth

(Get Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Featured Articles

Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.